Varian Medical Systems, Inc. (VAR) Shares Sold by GSA Capital Partners LLP

Share on StockTwits

GSA Capital Partners LLP trimmed its position in Varian Medical Systems, Inc. (NYSE:VAR) by 76.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 4,395 shares of the medical equipment provider’s stock after selling 14,199 shares during the quarter. GSA Capital Partners LLP’s holdings in Varian Medical Systems were worth $498,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Creative Planning raised its holdings in Varian Medical Systems by 0.8% in the 4th quarter. Creative Planning now owns 10,211 shares of the medical equipment provider’s stock valued at $1,157,000 after acquiring an additional 80 shares during the period. Utah Retirement Systems raised its holdings in Varian Medical Systems by 0.6% in the 4th quarter. Utah Retirement Systems now owns 17,078 shares of the medical equipment provider’s stock valued at $1,935,000 after acquiring an additional 100 shares during the period. First Personal Financial Services raised its holdings in Varian Medical Systems by 58.8% in the 4th quarter. First Personal Financial Services now owns 351 shares of the medical equipment provider’s stock valued at $40,000 after acquiring an additional 130 shares during the period. Contravisory Investment Management Inc. raised its holdings in Varian Medical Systems by 7.0% in the 4th quarter. Contravisory Investment Management Inc. now owns 2,793 shares of the medical equipment provider’s stock valued at $316,000 after acquiring an additional 182 shares during the period. Finally, Advisor Partners LLC raised its holdings in Varian Medical Systems by 9.8% in the 4th quarter. Advisor Partners LLC now owns 2,333 shares of the medical equipment provider’s stock valued at $264,000 after acquiring an additional 208 shares during the period. 91.95% of the stock is currently owned by institutional investors.

Shares of NYSE:VAR opened at $136.31 on Friday. Varian Medical Systems, Inc. has a 12-month low of $101.42 and a 12-month high of $137.67. The company has a market cap of $12.35 billion, a price-to-earnings ratio of 30.84, a price-to-earnings-growth ratio of 3.60 and a beta of 0.85.

Varian Medical Systems (NYSE:VAR) last announced its earnings results on Wednesday, January 23rd. The medical equipment provider reported $1.06 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.07 by ($0.01). Varian Medical Systems had a return on equity of 26.18% and a net margin of 12.28%. The business had revenue of $741.00 million for the quarter, compared to analyst estimates of $717.83 million. During the same quarter in the previous year, the company earned $1.06 EPS. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. Sell-side analysts expect that Varian Medical Systems, Inc. will post 4.7 earnings per share for the current year.

VAR has been the topic of several research analyst reports. Jefferies Financial Group increased their price target on shares of Varian Medical Systems to $145.00 and gave the company a “buy” rating in a report on Thursday, January 24th. Barrington Research reissued a “buy” rating on shares of Varian Medical Systems in a report on Thursday, January 24th. Zacks Investment Research raised shares of Varian Medical Systems from a “hold” rating to a “strong-buy” rating and set a $146.00 price target on the stock in a report on Saturday, January 26th. Citigroup lowered their price target on shares of Varian Medical Systems from $145.00 to $131.00 and set a “buy” rating on the stock in a report on Wednesday, January 2nd. Finally, Royal Bank of Canada increased their price target on shares of Varian Medical Systems to $130.00 and gave the company a “sector perform” rating in a report on Thursday, January 24th. One analyst has rated the stock with a sell rating, three have given a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $130.63.

In related news, Director R Andrew Eckert sold 5,651 shares of the stock in a transaction that occurred on Monday, January 28th. The shares were sold at an average price of $130.15, for a total transaction of $735,477.65. Following the sale, the director now owns 9,806 shares in the company, valued at approximately $1,276,250.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Magnus Momsen sold 2,800 shares of the stock in a transaction that occurred on Thursday, January 3rd. The stock was sold at an average price of $110.17, for a total transaction of $308,476.00. Following the sale, the chief accounting officer now owns 3,281 shares in the company, valued at approximately $361,467.77. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 47,466 shares of company stock worth $6,105,577. Company insiders own 0.74% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This article was first posted by Ticker Report and is owned by of Ticker Report. If you are accessing this article on another website, it was illegally stolen and reposted in violation of United States and international copyright and trademark law. The correct version of this article can be accessed at https://www.tickerreport.com/banking-finance/4223783/varian-medical-systems-inc-var-shares-sold-by-gsa-capital-partners-llp.html.

Varian Medical Systems Profile

Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment.

Further Reading: QQQ ETF

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

YoloCash  Market Cap Hits $15,461.00
YoloCash Market Cap Hits $15,461.00
VikkyToken Achieves Market Cap of $28,771.00
VikkyToken Achieves Market Cap of $28,771.00
Head to Head Analysis: Key Energy Services  vs. RPC
Head to Head Analysis: Key Energy Services vs. RPC
Colu Local Network  Price Up 4.3% This Week
Colu Local Network Price Up 4.3% This Week
Gladstone Capital Co.  Expected to Announce Earnings of $0.21 Per Share
Gladstone Capital Co. Expected to Announce Earnings of $0.21 Per Share
Bitcoin Gold Reaches Market Capitalization of $392.92 Million
Bitcoin Gold Reaches Market Capitalization of $392.92 Million


© 2006-2019 Ticker Report